Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Conatus Pharmaceuticals CNAT

Healthcare Biotechnology
Conatus Pharmaceuticals Inc is a biotechnology company focused on the development and commercialization of novel medicines to treat chronic diseases with significant unmet need. The company is developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease. Emricasan is designed to reduce the activities of human caspases, which are enzymes... see more

Bullboard (NDAQ:CNAT)

View:
1 2 3 Next
Post by Iseneschalon Mar 17, 2023 3:52pm

HSTO ..... Thanks for the dough Joe

Cheers to scalping   Money for nothing !
83
Post by Iseneschalon Mar 17, 2023 3:02pm

HSTO ..... U have to ask yourself....

How on earth does this trade 10 x's it's shares o/s and only be up 45 f'king cents  I smell a rat !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
66
Post by Iseneschalon Mar 17, 2023 2:47pm

HSTO..... I call this "No Mans Land"

I'm fairly certain of the direction....keeping that to myself for this moment.... $1.31  Cheers !
43
Post by Iseneschalon Mar 17, 2023 2:36pm

HSTO ..... just remember that this still isn't Strike 3 ; )

The last bastion of support hasn't been breached yet  Might still have legs
50
Post by Iseneschalon Mar 17, 2023 2:25pm

HSTO.... Well Strike 3 hasn't happened ; )

Iy's been all "sideways action" since my post I have support at $1.33 & resisitance at $1.47 Sideways action can be interesting... quite often u will get a breakout one way or the ...more  
70
Post by Iseneschalon Mar 17, 2023 12:02pm

HSTO..... not looking good with declining vols

Strike 3 fast approaching....with support at $1.27....then $1.20....with the last bastion of support at $1.05 Watch for rallies off my support targets.....vols are still there Me no position ...more  
55
Post by Iseneschalon Mar 17, 2023 11:08am

HSTO...... N.H.O.D

shouldn't have sold......but one has to be cautious
56
Post by Iseneschalon Mar 17, 2023 10:51am

HSTO ..... vols are declining

They are still good but 50% lower than the up volime on the 5 min chart
59
Post by Iseneschalon Mar 17, 2023 10:45am

HSTO ..... I'm done

Stopped out as planned
85
Post by Iseneschalon Mar 17, 2023 10:38am

HSTO ..... Thru RBL....careful here

Keep in mind that it's been doing this all morning Stops save Portfolios
45
1 2 3 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities